ResearcherBeijing University of Chinese MedicineNo recent work listed

Xing Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7480-5085; OpenAlex author ID A5100381472. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. Co-author DOI 10.3389/fphar.2023.1129662 ↗
Oridonin alters the expression profiles of microRNAs in BxPC-3 human pancreatic cancer cells. Co-author DOI 10.1186/s12906-015-0640-5 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xinyuan Shi · 1 shared paper, 2023 · strength 0.22
- Paper Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. DOI 10.3389/fphar.2023.1129662 ↗
Jian Xu · 1 shared paper, 2015 · strength 0.06
- Paper Oridonin alters the expression profiles of microRNAs in BxPC-3 human pancreatic cancer cells. DOI 10.1186/s12906-015-0640-5 ↗
Zhifang Gui · 1 shared paper, 2015 · strength 0.06
- Paper Oridonin alters the expression profiles of microRNAs in BxPC-3 human pancreatic cancer cells. DOI 10.1186/s12906-015-0640-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.